Home
Statistics
Acknowledgment
Enquire
Keyword Search
Complex Search
Segment Search
Peptide Mapping
Browse On
Mode of delivery
Animal model
Origin/Source
Peptide Length
Similarity
BLAST Search
Smith-Waterman
General
Help or Guide
Data Submission
Curators
Developers
Contact Us
Browse result page of B3Pdb
The total number entries retrieved from this search are
507
, scroll left/right for detailed information.
B3pdbID
PEPTIDE NAME
PEPTIDE SEQUENCE (1-letter)
PEPTIDE SEQUENCE (3-letter)
N-TERMINAL MODIFICATION
C-TERMINAL MODIFICATION
CHEMICAL MODIFICATION
PEPTIDE LENGTH
PEPTIDE CONFORMATION
PEPTIDE NATURE
SOURCE/ORIGIN OF PEPTIDE
SMILES
CELL LINE
In vitro
CONCENTRATION
In vitro
METHOD
In vitro
RESULT
ANIMAL MODEL
In vivo
CONCENTRATION
In vivo
MODE OF DELIVERY
In vivo
METHOD
In vivo
RESULT
ACTION
TRANSPORT TYPE
SUBCELLULAR LOCALISATION
COMBINATION
PHYSICAL CONDITION
RESPONSE
RESULT
LABEL
PMID
b3pdb_0701
SAM 1025
YcGFc-(β-D-Glc)sG-NH2
Tyr-(D)Cys-Gly-Phe-(D)Cys-(β-D-Glucose) (D)Ser-Gly-NH2
(D)Cys2-(D)Cys5
7
Linear
NA
Chemically synthesized
O=C(N)CNC(=O)[C@@H](NC(=O)[C@@H]2NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](NC(=O)[C@H](N)Cc1ccc(O)cc1)CSSC2)Cc3ccccc3)CO[C@@H]4OC(CO)[C@@H](O)C(O)[C@H]4O
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional flux rate constant,initial
0.00057 ml/(g x min)
Direct iodination
11033091
b3pdb_0702
SAM 1025
YcGFc-(β-D-Glc)sG-NH2
Tyr-(D)Cys-Gly-Phe-(D)Cys-(β-D-Glucose) (D)Ser-Gly-NH2
NA
NA
(D)Cys2-(D)Cys5
7
Linear
NA
Chemically synthesized
O=C(N)CNC(=O)[C@@H](NC(=O)[C@@H]2NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](NC(=O)[C@H](N)Cc1ccc(O)cc1)CSSC2)Cc3ccccc3)CO[C@@H]4OC(CO)[C@@H](O)C(O)[C@H]4O
NA
NA
Shake Flask
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
Log D
-1.252
Direct iodination
11033091
b3pdb_0703
SAM 1040
YcGFc-(β-D-Xyl)SG-NH2
Tyr-(D)Cys-Gly-Phe-(D)Cys-(β-D-Xylose)Ser-Gly-NH2
(D)Cys2-(D)Cys5
7
Linear
NA
Chemically synthesized
O=C(N)CNC(=O)[C@H](NC(=O)[C@@H]2NC(=O)[C@H](NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CSSC2)Cc3ccccc3)CO[C@@H]4O[C@H](CO)C(O)[C@@H]4O
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional flux rate constant,initial
0.00133 ml/(g x min)
Direct iodination
11033091
b3pdb_0704
SAM 1040
YcGFc-(β-D-Xyl)SG-NH2
Tyr-(D)Cys-Gly-Phe-(D)Cys-(β-D-Xylose)Ser-Gly-NH2
NA
NA
(D)Cys2-(D)Cys5
7
Linear
NA
Chemically synthesized
O=C(N)CNC(=O)[C@H](NC(=O)[C@@H]2NC(=O)[C@H](NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CSSC2)Cc3ccccc3)CO[C@@H]4O[C@H](CO)C(O)[C@@H]4O
NA
NA
Shake Flask
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
Log D
-1.495
Direct iodination
11033091
b3pdb_0705
Dynorphin (1-13)
YGGFLRRIRPKLK
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys
NA
NA
NA
13
Linear
NA
Chemically synthesized
O=C(NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CCCCN)CC(C)C)CCCCN)CCC1)CCCNC(=[N@H])N)C(C)CC)CCCNC(=[N@H])N)CCCNC(=[N@H])N)CC(C)C)Cc2ccccc2)CNC(=O)C(N)Cc3ccc(O)cc3
NA
NA
BUI method
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
BUI
0.14%
H3/C14
9639252
b3pdb_0706
NAP
NAPVSIPQ
Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln
NA
NA
NA
8
Linear
NA
Chemically synthesized
O=C(NC(C(=O)O)CCC(=O)N)C2N(C(=O)C(NC(=O)C(NC(=O)C(NC(=O)C1N(C(=O)C(NC(=O)C(N)CC(=O)N)C)CCC1)C(C)C)CO)C(C)CC)CCC2
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
b3pdb_0708
Cyclo (His-Pro)
c(HP)
Cyclo (His-Pro)
NA
NA
NA
2
Linear
NA
Chemically synthesized
O=C1N3[C@@H](C(=O)N[C@@H]1Cc2ncnc2)CCC3
NA
NA
Shake Flask
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
Log P
-0.09
Direct iodination
8498494
b3pdb_0709
Cyclo (His-Pro)
c(HP)
Cyclo (His-Pro)
NA
2
Linear
NA
Chemically synthesized
O=C1N3[C@@H](C(=O)N[C@@H]1Cc2ncnc2)CCC3
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
NA
NA
NA
NA
Unidirectional influx rate constant
0.00018 mL/(g x min)
Direct iodination
11033091
b3pdb_0710
Cyclo (His-Pro)
c(HP)
Cyclo (His-Pro)
NA
NA
NA
2
Cyclic
NA
Chemically synthesized
O=C1N3[C@@H](C(=O)N[C@@H]1Cc2ncnc2)CCC3
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
0.000179 mL/(g x min)
Direct iodination
8498494
b3pdb_0711
Cyclo (His-Pro)
c(HP)
Cyclo (His-Pro)
NA
NA
NA
2
Cyclic
NA
Chemically synthesized
O=C1N3[C@@H](C(=O)N[C@@H]1Cc2ncnc2)CCC3
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Initial disrobution volume
0.0239 ml/g
Direct iodination
8498494
b3pdb_0712
Cyclo (His-Pro)
c(HP)
Cyclo (His-Pro)
NA
NA
NA
2
Cyclic
NA
Chemically synthesized
O=C1N3[C@@H](C(=O)N[C@@H]1Cc2ncnc2)CCC3
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
half life, brain
25.6 min
Direct iodination
8498494
b3pdb_0713
Cyclo (His-Pro)
c(HP)
Cyclo (His-Pro)
NA
NA
NA
2
Cyclic
NA
Chemically synthesized
O=C1N3[C@@H](C(=O)N[C@@H]1Cc2ncnc2)CCC3
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Brain elimination rate constant
0.0118 min-1
Direct iodination
8498494
b3pdb_0716
human Obestatin
FNAPFDVGIKLSGVQYQQHSQAL-NH2
Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Val-Gln-Tyr-Gln-Gln-His-Ser-Gln-Ala-Leu-NH2
NA
NA
NA
23
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
b3pdb_0717
Angiotensin II
DRVYIHPFHL
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu
NA
NA
NA
10
Linear
NA
Chemically synthesized
O=C(O)CC(N)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(C)C)Cc1cncn1)Cc2ccccc2)CCC3)Cc4cncn4)C(C)CC)Cc5ccc(O)cc5)C(C)C)CCCNC(=[N@H])N
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
b3pdb_0726
BQ123
c(wdPvL)
cyclo(–(D)Trp–(D)Asp–Pro–(D)Val–Leu)
NA
NA
NA
5
Linear
NA
Chemically synthesized
O=C(O)C[C@@H]1C(=O)N4[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N1)Cc3c2ccccc2nc3)CC(C)C)C(C)C)CCC4
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
b3pdb_0727
[(D)Ala2, (N-Me)Phe4
YaG-(N-Me)F-G-OH
Tyr-(D)Ala-Gly-(N-Me)Phe-Gly-OH
NA
NA
NA
5
Linear
NA
Chemically synthesized
O=C(NCCO)C(N(C(=O)CNC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)C)Cc2ccccc2
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
half life, brain
10.66 min
Direct iodination
20347901
b3pdb_0728
[(D)Ala2, (N-Me)Phe4
YaG-(N-Me)F-G-OH
Tyr-(D)Ala-Gly-(N-Me)Phe-Gly-OH
NA
NA
NA
5
Linear
NA
Chemically synthesized
O=C(NCCO)C(N(C(=O)CNC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)C)Cc2ccccc2
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Brain elemination rate constant
0.065 min-1
Direct iodination
20347901
b3pdb_0729
[(D)Ala2, (N-Me)Phe4
YaG-(N-Me)F-G-OH
Tyr-(D)Ala-Gly-(N-Me)Phe-Gly-OH
NA
NA
NA
5
Linear
NA
Chemically synthesized
O=C(NCCO)C(N(C(=O)CNC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)C)Cc2ccccc2
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
7.30%
Direct iodination
20347901
b3pdb_0730
[(D)Ala2, (N-Me)Phe4
YaG-(N-Me)F-G-OH
Tyr-(D)Ala-Gly-(N-Me)Phe-Gly-OH
NA
NA
NA
5
Linear
NA
Chemically synthesized
O=C(NCCO)C(N(C(=O)CNC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)C)Cc2ccccc2
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
92.70%
Direct iodination
20347901
b3pdb_0731
[(D)Ala2, (N-Me)Phe4
YaG-(N-Me)F-G-OH
Tyr-(D)Ala-Gly-(N-Me)Phe-Gly-OH
NA
NA
NA
5
Linear
NA
Chemically synthesized
O=C(NCCO)C(N(C(=O)CNC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)C)Cc2ccccc2
NA
NA
HPLC
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
half life, serum
200 min
Direct iodination
20347901
b3pdb_0732
[(D)Ala2, (N-Me)Phe4
YaG-(N-Me)F-G-OH
Tyr-(D)Ala-Gly-(N-Me)Phe-Gly-OH
NA
NA
NA
5
Linear
NA
Chemically synthesized
O=C(NCCO)C(N(C(=O)CNC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)C)Cc2ccccc2
NA
NA
HPLC
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
half life, brain
900 min
Direct iodination
20347901
b3pdb_0733
[(D)Ala2, (N-Me)Phe4
YaG-(N-Me)F-G-OH
Tyr-(D)Ala-Gly-(N-Me)Phe-Gly-OH
NA
NA
NA
5
Linear
NA
Chemically synthesized
O=C(NCCO)C(N(C(=O)CNC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)C)Cc2ccccc2
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
0.0004 mL/(g x min)
Direct iodination
20347901
b3pdb_0734
[(D)Ala2, (N-Me)Phe4
YaG-(N-Me)F-G-OH
Tyr-(D)Ala-Gly-(N-Me)Phe-Gly-OH
NA
NA
NA
5
Linear
NA
Chemically synthesized
O=C(NCCO)C(N(C(=O)CNC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)C)Cc2ccccc2
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Initial disrobution volume
0.03453 ml/g
Direct iodination
20347901
b3pdb_0735
(D)Trp11-Neurotensin
Pyr-LYENKPRRPwIL
Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-(D)Trp-Ile-Leu
NA
NA
NA
13
Linear
NA
Chemically synthesized
O=C(O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC(C)C)Cc2ccc(O)cc2)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N3CCC[C@@H]3C(=O)N[C@H](C(=O)N[C@@H](C(=O)N6[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)O)[C@H](C)CC)[C@@H](C)CC)Cc5c4ccccc4nc5)CCC6)CCCNC(=[N@H])N)CCCNC(=[N@H])N)CCCCN)CC(=O)N
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
b3pdb_0736
PGP
PGP
Pro-Gly-Pro
NA
NA
NA
3
Linear
NA
Chemically synthesized
O=C(N1C(C(=O)O)CCC1)CNC(=O)C2NCCC2
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
b3pdb_0737
Teneurin C-terminal
QQLLGTGRVQGYDGYFVLSVEQYLELSDSANNIHFMRQSEI-NH2
Gln-Gln-Leu-Leu-Gly-Thr-Gly-Arg-Val-Gln-Gly-Tyr-Asp-Gly-Tyr-Phe-Val-Leu-Ser-Val-Glu-Gln-Tyr-Leu-Glu-Leu-Ser-Asp-Ser-Ala-Asn-Asn-Ile-His-Phe-Met-Arg-Gln-Ser-Glu-Ile-NH2
NA
NA
NA
41
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
b3pdb_0738
Adrenocorticotropic
MEHFRW
Met-Glu-His-Phe-Arg-Trp
NA
NA
NA
6
Linear
NA
Chemically synthesized
O=C(O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)CCSC)CCC(=O)O)Cc1cncn1)Cc2ccccc2)CCCNC(=[N@H])N)Cc4c3ccccc3nc4
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
b3pdb_0740
Semax
MEHFPGP
Met-Glu-His-Phe-Pro-Gly-Pro
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(N1C(C(=O)O)CCC1)CNC(=O)C4N(C(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)CCSC)CCC(=O)O)Cc2cncn2)Cc3ccccc3)CCC4
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
b3pdb_0741
TAPA
YrF-βA
Tyr-(D)Arg-Phe-βAla
NA
NA
NA
4
Linear
NA
Chemically synthesized
O=C(O)CCNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CCCNC(=[N@H])N)Cc2ccccc2
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
saturable
NA
NA
NA
Unidirectional influx rate constant
0.000265 mL/(g x min)
Direct iodination
12603838
b3pdb_0742
TAPA
YrF-βA
Tyr-(D)Arg-Phe-βAla
NA
NA
NA
4
Linear
NA
Chemically synthesized
O=C(O)CCNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CCCNC(=[N@H])N)Cc2ccccc2
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
saturable
NA
NA
NA
Initial disrobution volume
0.00869 ml/g
Direct iodination
12603838
b3pdb_0743
Substance P
RPKPQQFFGLM-NH2
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2
NA
NA
NA
11
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C2N(C(=O)C(NC(=O)C1N(C(=O)C(N)CCCNC(=[N@H])N)CCC1)CCCCN)CCC2)CCC(=O)N)CCC(=O)N)Cc3ccccc3)Cc4ccccc4)CC(C)C)CCSC
NA
NA
NA
NA
NA
NA
Intracarotid injection
NA
NA
NA
Permeability
NA
NA
NA
Blood/brain ratio
258
Direct iodination
2413968
b3pdb_0744
Dalargin
YaGFLR
Tyr-(D)Ala-Gly-Phe-Leu-Arg
NA
NA
NA
6
Linear
NA
Chemically synthesized
O=C(O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C)Cc2ccccc2)CC(C)C)CCCNC(=[N@H])N
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Volume of donor compartment
0.0167 ml/g
H3/C14
12682214
b3pdb_0746
TAPS
YrFSar
Tyr-(D)Arg-Phe-Sar
NA
NA
NA
4
Linear
NA
Chemically synthesized
O=C(O)CN(C(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CCCNC(=[N@H])N)Cc2ccccc2)C
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
14.33%
Direct iodination
20347901
b3pdb_0747
TAPS
YrFSar
Tyr-(D)Arg-Phe-Sar
NA
NA
NA
4
Linear
NA
Chemically synthesized
O=C(O)CN(C(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CCCNC(=[N@H])N)Cc2ccccc2)C
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
85.67%
Direct iodination
20347901
b3pdb_0748
TAPS
YrFSar
Tyr-(D)Arg-Phe-Sar
NA
NA
NA
4
Linear
NA
Chemically synthesized
O=C(O)CN(C(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CCCNC(=[N@H])N)Cc2ccccc2)C
NA
NA
HPLC
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
half life, serum
200 min
Direct iodination
20347901
b3pdb_0749
TAPS
YrFSar
Tyr-(D)Arg-Phe-Sar
NA
NA
NA
4
Linear
NA
Chemically synthesized
O=C(O)CN(C(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CCCNC(=[N@H])N)Cc2ccccc2)C
NA
NA
HPLC
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
half life, brain
900 min
Direct iodination
20347901
b3pdb_0750
TAPS
YrFSar
Tyr-(D)Arg-Phe-Sar
NA
NA
NA
4
Linear
NA
Chemically synthesized
O=C(O)CN(C(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CCCNC(=[N@H])N)Cc2ccccc2)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
0.00018 mL/(g x min)
Direct iodination
20347901
b3pdb_0751
TAPS
YrFSar
Tyr-(D)Arg-Phe-Sar
NA
NA
NA
4
Linear
NA
Chemically synthesized
O=C(O)CN(C(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CCCNC(=[N@H])N)Cc2ccccc2)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Initial disrobution volume
0.01859 ml/g
Direct iodination
20347901
b3pdb_0760
CTOP
fCYwOrnTPenT-NH2
(D)Phe-Cys-Tyr-(D)Trp-Orn-Thr-Pen-Thr-NH2
NA
NA
Cys2-Pen7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCN)C(O)C)C(O)C
NA
NA
HPLC
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
half life, serum
200 min
Direct iodination
20347901
b3pdb_0761
CTOP
fCYwOrnTPenT-NH2
(D)Phe-Cys-Tyr-(D)Trp-Orn-Thr-Pen-Thr-NH2
NA
NA
Cys2-Pen7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCN)C(O)C)C(O)C
NA
NA
HPLC
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
half life, brain
900 min
Direct iodination
20347901
b3pdb_0762
CTOP
fCYwOrnTPenT-NH2
(D)Phe-Cys-Tyr-(D)Trp-Orn-Thr-Pen-Thr-NH2
NA
NA
Cys2-Pen7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCN)C(O)C)C(O)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
0.00024 mL/(g x min)
Direct iodination
20347901
b3pdb_0763
CTOP
fCYwOrnTPenT-NH2
(D)Phe-Cys-Tyr-(D)Trp-Orn-Thr-Pen-Thr-NH2
NA
NA
Cys2-Pen7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCN)C(O)C)C(O)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Initial disrobution volume
0.01894 ml/g
Direct iodination
20347901
b3pdb_0764
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
10.29%
Direct iodination
20347901
b3pdb_0765
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
89.71%
Direct iodination
20347901
b3pdb_0766
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
Antinociception
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
ICV/SC ratio
0.0000114
NA
9723966
b3pdb_0767
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
saturable
NA
NA
NA
Unidirectional influx rate constant
0.00218 mL/(g x min)
Direct iodination
20347901
b3pdb_0768
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
saturable
NA
NA
NA
Initial disrobution volume
0.02148 ml/g
Direct iodination
20347901
b3pdb_0769
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.01398 ml/g
Direct iodination
26465925
b3pdb_0770
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00063 mL/(g x min)
Direct iodination
26465925
b3pdb_0771
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00019 mL/(g x min)
Direct iodination
24164260
previous
1
2
3
4
5
6
7
8
9
10
11
next
IIITD/CB
Raghava's Group
IMTECH
CellPPDMOD